相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential Effect of Telmisartan and Amlodipine on Monocyte Chemoattractant Protein-1 and Peroxisome Proliferator-Activated Receptor-Gamma Gene Expression in Peripheral Monocytes in Patients With Essential Hypertension
Maria E. Marketou et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice
Debra L. Rateri et al.
CIRCULATION RESEARCH (2011)
A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal
Husam Ghanim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Julius Benicky et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The gut microbiome as therapeutic target
Patrice D. Cani et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Blockade of brain angiotensin II AT(1) receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
Juan M. Saavedra et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Nutrient Modification of the Innate Immune Response A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation
Eric A. Schwartz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Losartan inhibits LPS-induced inflammatory signaling through a PPARγ-dependent mechanism in human THP-1 macrophages
Jianbo An et al.
HYPERTENSION RESEARCH (2010)
PPAR Modulation of Kinase-Linked Receptor Signaling in Physiology and Disease
Nicolas Rotman et al.
PHYSIOLOGY (2010)
Key Role of CD36 in Toll-Like Receptor 2 Signaling in Cerebral Ischemia
Takato Abe et al.
STROKE (2010)
The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade
Steven G. Chrysant et al.
CURRENT CLINICAL PHARMACOLOGY (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
In vivo Angiotensin II AT(1) receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland
Enrique Sanchez-Lemus et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Crosstalk between peroxisome proliferator-activated receptor-γ and angiotensin II in renal tubular epithelial cells in IgA nephropathy
Jing Xiao et al.
CLINICAL IMMUNOLOGY (2009)
PPARγ and its ligands: therapeutic implications in cardiovascular disease
Luis Villacorta et al.
CLINICAL SCIENCE (2009)
PPARs: the vasculature, inflammation and hypertension
Sheng Zhong Duan et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Inhibition of Tumor Necrosis Factor-α-Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer- Binding Protein-β
Qingping Tian et al.
HYPERTENSION (2009)
Cognitive Deficit in Amyloid-β-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
Kana Tsukuda et al.
HYPERTENSION (2009)
The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality
Panagiotis C. Stafylas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
Ignacio M. Larrayoz et al.
JOURNAL OF HYPERTENSION (2009)
PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway
Yuanyuan Ji et al.
LABORATORY INVESTIGATION (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-α and interferon-γ inflammatory effects in human endothelial cells
Adriana Lombardi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
Bin Xing et al.
JOURNAL OF NEUROINFLAMMATION (2008)
PPAR activation: A new target for the treatment of hypertension
Eyal Leibovitz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
Carmine Savoia et al.
CLINICAL SCIENCE (2007)
Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR-γ
Stefan Zorad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Molecular activation of PPAR gamma by angiotensin II type 1-receptor antagonists
David V. Erbe et al.
VASCULAR PHARMACOLOGY (2006)
Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor γ levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients
L Klotz et al.
JOURNAL OF IMMUNOLOGY (2005)
Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-κB activity in lipopolysaccharide-activated human primary monocytes
YB Lu et al.
JOURNAL OF IMMUNOLOGY (2005)
Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats
J Zhou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2:: implications for atherosclerotic plaque rupture
MP Kim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Microarray analysis of peroxisome proliferator-activated receptor γ-induced changes in gene expression in macrophages
CP Hodgkinson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
C Bregonzio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
DM Tham et al.
PHYSIOLOGICAL GENOMICS (2002)
Inhibition of the transcription factors AP-1 and NF-κB in CD4 T cells by peroxisome proliferator-activated receptor γ ligands
P Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
SW Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
J Stangier et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2000)
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress
ME Pueyo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
